IVDR Performance Evaluation: From Planning to Reporting

Performance Evaluation Under IVDR

Performance evaluation is a cornerstone of IVDR compliance. Article 56 and Annex XIII establish comprehensive requirements for demonstrating that IVD devices achieve their intended performance and are safe for their intended purpose.

The Three Pillars of Performance Evaluation

IVDR structures performance evaluation around three interconnected components:

Scientific Validity refers to the association of an analyte with a clinical condition or physiological state. Manufacturers must demonstrate that the measurand (the quantity intended to be measured) has a well-established scientific basis. This typically involves a literature review of peer-reviewed publications, clinical guidelines, and consensus standards.

Analytical Performance encompasses the technical performance characteristics of the device, including:

1. Sensitivity and specificity (for qualitative devices)
2. Accuracy, precision, and trueness (for quantitative devices)
3. Measuring range and linearity
4. Limit of detection and limit of quantitation
5. Interfering substances and cross-reactivity
6. Sample stability and robustness

Clinical Performance demonstrates that the device provides results relevant to clinical decision-making in the target population. This may involve clinical performance studies, comparison with reference methods, or analysis of published clinical data.

Performance Evaluation Plan

Before conducting any studies, manufacturers must establish a Performance Evaluation Plan (PEP) that defines:

1. The scope and objectives of the evaluation
2. The performance characteristics to be assessed
3. The study designs and methodologies to be used
4. Statistical analysis plans and acceptance criteria
5. The types and sources of data to be collected

Performance Evaluation Report

The Performance Evaluation Report (PER) documents the results of all performance evaluation activities and provides a comprehensive assessment of the device's performance. The PER must:

1. Summarize all available performance data
2. Critically evaluate the quality and relevance of the data
3. Identify any gaps in the evidence
4. Conclude on whether the device meets its intended performance
5. Define the need for any post-market performance follow-up (PMPF)

Post-Market Performance Follow-Up

IVDR introduces the concept of Post-Market Performance Follow-Up (PMPF) as an ongoing obligation. Manufacturers must proactively collect and evaluate performance data throughout the device lifecycle to confirm continued safety and performance.

Conclusion

A well-planned and thoroughly documented performance evaluation is essential for IVDR compliance. Manufacturers should invest adequate time and resources in this critical activity, as it forms the scientific foundation of their regulatory submission.